Gut microbiota – a new companion on the path of cardiovascular diseases progression: surprising roles of long-time neighbors
The last decade is marked by the significant reinterpretation of the gut microbiota contribution to chronic disease progression. The researchers’ careful attention is focused on improving the understanding of the metabolic pathways of two dietary compounds – choline and L-carnitine, which stand at t...
Saved in:
| Main Authors: | O. M. Drapkina, A. N. Kaburova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1203 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development
by: O. M. Drapkina, et al.
Published: (2020-05-01) -
Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential
by: I. N. Grigorieva
Published: (2022-09-01) -
Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome
by: O. M. Drapkina, et al.
Published: (2018-09-01) -
Impacts of intestinal microbiota metabolite trimethylamine N-oxide on cardiovascular disease: a bibliometric analysis
by: Xiaohui Leng, et al.
Published: (2025-01-01) -
Role of intestinal microbiota changes in cardiovascular diseases pathogenesis
by: V. H. Lyzohub, et al.
Published: (2019-10-01)